Myelofibrosis disrupts blood cell production. It results in scarring in the bone marrow (fibrosis). This leads to weakness, fatigue, and, often, an enlarged spleen and liver. Myelofibrosis is a type of chronic leukemia, a cancer.


Treatment may not be needed early on. Later, treatment aims to relieve symptoms.

Last Updated Mar 3, 2020

© 2023 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Terms of Use